Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
Saved in:
| Title: | Recombinant vesicular stomatitis vaccine against nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. |
|---|---|
| Authors: | Monath, Thomas P.1,2 (AUTHOR) tom.monath@crozetbiopharma.com, Nichols, Richard1,2 (AUTHOR), Tussey, Lynda1,2 (AUTHOR), Scappaticci, Kelly1,2 (AUTHOR), Pullano, Thaddeus G.1 (AUTHOR), Whiteman, Mary D.3 (AUTHOR), Vasilakis, Nikos4,5 (AUTHOR), Rossi, Shannan L.4 (AUTHOR), Campos, Rafael Kroon4 (AUTHOR), Azar, Sasha R.4 (AUTHOR), Spratt, Heidi M.6 (AUTHOR), Seaton, Brent L.7 (AUTHOR), Archambault, W. Tad8 (AUTHOR), Costecalde, Yanina V.9,10 (AUTHOR), Moore, Evan H.10 (AUTHOR), Hawks, Roger J.10 (AUTHOR), Fusco, Joan1,2 (AUTHOR) |
| Source: | PLoS Pathogens. 6/27/2022, Vol. 18 Issue 6, p1-25. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
